Shenzhen Kisshealth Biotechnology Co., Ltd

Keep It Simply and Smartly for Healthcare!

Manufacturer from China
Active Member
4 Years
Home / Products / Antibody Test Kit /

Serum Coronavirus Antibodies Detection Kit Latex Particle Enhanced Turbidimetric Immunoassay

Contact Now
Shenzhen Kisshealth Biotechnology Co., Ltd
City:shenzhen
Country/Region:china
Contact Person:MsMeiko Wu
Contact Now

Serum Coronavirus Antibodies Detection Kit Latex Particle Enhanced Turbidimetric Immunoassay

Ask Latest Price
Video Channel
Brand Name :KISSH
Model Number :K217-200
Certification :CE
Place of Origin :CHINA
MOQ :1000 tests
Payment Terms :T/T
Supply Ability :1,000,000 tests per day
Delivery Time :Within 7 days
Packaging Details :100 tests/kit,200 tests/kit, 300 tests/kit,500Tests/Kit
Product name :SARS-CoV-2 Antibodies Detection Kit (Latex particle-enhanced turbidimetric immunoassay)
Brand :KISSH
Sampling :Serum
Package :200 test/kit
more
Contact Now

Add to Cart

Find Similar Videos
View Product Description

SARS-CoV-2 Antibodies Detection Kit (Latex particle-enhanced turbidimetric immunoassay)

Product information

Product name

SARS-CoV-2 Antibodies Detection Kit (Latex particle-enhanced turbidimetric immunoassay)

Application

Qualitative and semi-quantitative detection of antibodies to SARS-CoV-2 spike (S) protein receptor binding domain (RBD) in human serum .

Specimen

Serum

Usage

For in vitro diagnostic use

Model

K218-200

Brand

KISSH

Product Description

Intended use of SARS-CoV-2 Antibodies Test Kit(Latex particle-enhanced turbidimetric immunoassay) is qualitative and semi-quantitative detection of antibodies to SARS-CoV-2 spike (S) protein receptor binding domain (RBD) in human serum.

Upon infection with SARS-CoV-2, the host mounts an immune response against the virus, typically including production of specific antibodies against viral antigens. IgM and IgG antibodies to SARS-CoV-2 appear to arise nearly simultaneously in blood.There is significant inter-individual difference in the levels and chronological appearance of antibodies in COVID-19 patients, but median seroconversion has been observed at approximately 2 weeks.

Serologic assays can play an important role in understanding viral epidemiology in the general population.

The SARS-CoV-2 Antibodies Test Kit(Latex particle-enhanced turbidimetric immunoassay) uses a recombinant protein representing the RBD of the S antigen .

Inquiry Cart 0